---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-064745"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T09:02:31.394412+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LifeStance Q1 revenue $333M (+11%), first positive net income as public company

## Summary
- Revenue $333M (+11% YoY); net income $0.7M vs net loss $21.1M in Q1 2024.
- Adjusted EBITDA $34.6M (+25% YoY); Center Margin $109.8M (33.0% of revenue).
- Clinician base grew to 7,535 (+10% YoY); visit volumes 2.1M (+10%).
- FY 2025 guidance reaffirmed: revenue $1.40B-$1.44B, Adj EBITDA $130M-$150M.
- Q2 2025 guidance: revenue $332M-$352M, Adj EBITDA $28M-$34M.

## SEC filing metadata
- accession: 0000950170-25-064745
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000095017025064745/0000950170-25-064745-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000095017025064745/lfst-20250507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-064745
- JSON: https://secwatch.observer/filing/0000950170-25-064745.json
- Plain text: https://secwatch.observer/filing/0000950170-25-064745.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.